Effect of pH on binding of agonists and antagonists to rat heart muscarinic receptors. 1983

J Asselin, and M Waelbroeck, and P Robberecht, and P de Neef, and J Christophe

The pH-dependence of antagonist and agonist binding to rat heart muscarinic receptors was investigated at 25 degrees C, in the absence and in the presence of GTP. The small inhibitory effect observed at the lowest pH investigated (pH 6.0) on [N-methyl-3H]methscopolamine chloride and [methyl-3H]oxotremorine-M acetate binding indicated that one or more amino acid residues of the receptor had to be deprotonated for optimal binding affinity. The low pK value of these residues (between 5 and 6) prevented their identification. The binding of scopolamine (pK 7.6) was favoured by a positive charge in the titratable amine, but binding with a lower affinity remained possible charge in the titratable amine, but binding with a lower affinity remained possible without this charge. GTP did not affect antagonist binding at any pH, but converted more than 90% of agonist binding sites into a low affinity conformation. In the absence of GTP, we observed a time- and pH-dependent conversion of the super-high- and high-affinity receptors to a low-affinity GTP-insensitive state. This conversion was markedly accelerated at high pH (above pH 8.0). In the presence of GTP, a positive charge on the titratable amine of pilocarpine (pK 7.05) and oxotremorine (pK 8.60) was required for binding. These results support the view that antagonist (e.g. methscopolamine) binding to receptors was largely facilitated by hydrophobic interactions, whereas agonist binding to low-affinity sites was mainly driven by ionic interactions.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008954 Models, Biological Theoretical representations that simulate the behavior or activity of biological processes or diseases. For disease models in living animals, DISEASE MODELS, ANIMAL is available. Biological models include the use of mathematical equations, computers, and other electronic equipment. Biological Model,Biological Models,Model, Biological,Models, Biologic,Biologic Model,Biologic Models,Model, Biologic
D009206 Myocardium The muscle tissue of the HEART. It is composed of striated, involuntary muscle cells (MYOCYTES, CARDIAC) connected to form the contractile pump to generate blood flow. Muscle, Cardiac,Muscle, Heart,Cardiac Muscle,Myocardia,Cardiac Muscles,Heart Muscle,Heart Muscles,Muscles, Cardiac,Muscles, Heart
D010095 Oxotremorine A non-hydrolyzed muscarinic agonist used as a research tool. Oxytremorine
D010277 Parasympathomimetics Drugs that mimic the effects of parasympathetic nervous system activity. Included here are drugs that directly stimulate muscarinic receptors and drugs that potentiate cholinergic activity, usually by slowing the breakdown of acetylcholine (CHOLINESTERASE INHIBITORS). Drugs that stimulate both sympathetic and parasympathetic postganglionic neurons (GANGLIONIC STIMULANTS) are not included here. Parasympathomimetic Agents,Parasympathomimetic Drugs,Parasympathomimetic Effect,Parasympathomimetic Effects,Agents, Parasympathomimetic,Drugs, Parasympathomimetic,Effect, Parasympathomimetic,Effects, Parasympathomimetic
D010862 Pilocarpine A slowly hydrolyzed muscarinic agonist with no nicotinic effects. Pilocarpine is used as a miotic and in the treatment of glaucoma. Isopilocarpine,Isoptocarpine,Ocusert,Pilocarpine Hydrochloride,Pilocarpine Mononitrate, (3S-cis)-Isomer,Pilocarpine Nitrate,Pilocarpine, Monohydrochloride, (3S-cis)-Isomer,Salagen,Hydrochloride, Pilocarpine,Nitrate, Pilocarpine
D011976 Receptors, Muscarinic One of the two major classes of cholinergic receptors. Muscarinic receptors were originally defined by their preference for MUSCARINE over NICOTINE. There are several subtypes (usually M1, M2, M3....) that are characterized by their cellular actions, pharmacology, and molecular biology. Muscarinic Acetylcholine Receptors,Muscarinic Receptors,Muscarinic Acetylcholine Receptor,Muscarinic Receptor,Acetylcholine Receptor, Muscarinic,Acetylcholine Receptors, Muscarinic,Receptor, Muscarinic,Receptor, Muscarinic Acetylcholine,Receptors, Muscarinic Acetylcholine
D002217 Carbachol A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS. Carbamylcholine,Carbacholine,Carbamann,Carbamoylcholine,Carbastat,Carbocholine,Carboptic,Doryl,Isopto Carbachol,Jestryl,Miostat,Carbachol, Isopto
D002462 Cell Membrane The lipid- and protein-containing, selectively permeable membrane that surrounds the cytoplasm in prokaryotic and eukaryotic cells. Plasma Membrane,Cytoplasmic Membrane,Cell Membranes,Cytoplasmic Membranes,Membrane, Cell,Membrane, Cytoplasmic,Membrane, Plasma,Membranes, Cell,Membranes, Cytoplasmic,Membranes, Plasma,Plasma Membranes
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations

Related Publications

J Asselin, and M Waelbroeck, and P Robberecht, and P de Neef, and J Christophe
January 1976, Journal of supramolecular structure,
J Asselin, and M Waelbroeck, and P Robberecht, and P de Neef, and J Christophe
December 1983, Journal of neurochemistry,
J Asselin, and M Waelbroeck, and P Robberecht, and P de Neef, and J Christophe
September 1984, Biochemical pharmacology,
J Asselin, and M Waelbroeck, and P Robberecht, and P de Neef, and J Christophe
November 1979, British journal of pharmacology,
J Asselin, and M Waelbroeck, and P Robberecht, and P de Neef, and J Christophe
September 1981, Biochemical and biophysical research communications,
J Asselin, and M Waelbroeck, and P Robberecht, and P de Neef, and J Christophe
February 1988, Trends in pharmacological sciences,
J Asselin, and M Waelbroeck, and P Robberecht, and P de Neef, and J Christophe
September 1977, Brain research,
J Asselin, and M Waelbroeck, and P Robberecht, and P de Neef, and J Christophe
June 1989, British journal of pharmacology,
J Asselin, and M Waelbroeck, and P Robberecht, and P de Neef, and J Christophe
September 1978, Molecular pharmacology,
J Asselin, and M Waelbroeck, and P Robberecht, and P de Neef, and J Christophe
February 1986, Journal of neurochemistry,
Copied contents to your clipboard!